SENS Research Foundation Board of Directors

SENS Research Foundation has been formed with the highest regard to best practice in governance. The following individuals have joined the SRF Board to lend their vision and guidance to our mission.

Andrew Aiello

Andrew Aiello is a digital development & marketing expert that leads successful campaigns and development projects for several fortune 500 companies and non-profit organizations. He is a Google certified professional who regularly attends Google’s annual All Stars Summit in Mountain View, California, and is experienced in various online marketing disciplines including paid search, SEO, and programmatic campaigns. Andrew clearly demonstrates how these digital tools can grow any type of organization. He has led and continues to lead highly successful digital development and marketing campaigns for local and national firms. Andrew graduated with a bachelor’s in communication design from Pratt Institute, Brooklyn, NY.

Keith Comito


Keith Comito is a mathematician, computer programmer, and leading advocate for research aimed at extending healthy human lifespan. In addition to developing foundational infrastructure for high-profile media applications such as HBO NOW and Disney+, he is also the inventor of several technologies relating to digital biomarkers, media streaming, extended reality, and decentralized science (DeSci). 

Seeing age-related disease as one of the most profound problems facing humanity, he works to accelerate and democratize longevity research efforts through initiatives such as, A4LI, and VitaDAO. He has developed novel neuroscience / DeSci projects, participated in numerous speaking engagements and press appearances around the world, and has produced several high-impact media projects to inform and engage the public regarding aging research.

In the past he has created popular video games, musical applications, and biotechnology projects featured in Forbes and NPR – such as his work with the Brooklyn community lab Genspace, where he helped create games which allow players to direct the motion of microscopic organisms using galvanotaxis. He earned a B.S. in Mathematics, B.S. in Computer science, and M.S. in Applied Mathematics at Hofstra University, where his work included analysis of the LMNA protein.

Kevin Dewalt

Kevin Dewalt has 30 years experience as an entrepreneur, investor and technology innovator. He is currently founder and CEO of Prolego, a specialist AI startup which  helps Fortune 500 companies generate billion-dollar revenue opportunities. At In-Q-Tel he helped make over 25 venture capital investments of more than $20M. He worked with Palantir founder Stephen Cohen to deploy the company’s first AI product in the US Intelligence community. At FINRA he ran the machine learning systems which detect anomalies in the billions of NASDAQ stock market events. As CMO of MadKudu he helped transform a data science application into the predictive intelligence sales platform used by Silicon Valley powerhouses Segment.

One of the original advocates of Lean Startup, Kevin is a recognized global leader in helping startups and corporate teams systematically drive innovation. He helped the National Science Foundation create the I-CORPS program and launch the first class with Steve Blank at Stanford.

He graduated #1 in his US Coast Guard Academy class with a degree in Electrical Engineering. His expertise in AI began at Stanford University while earning his Master’s Degree and completing original research under legend Dr. Bernard Widrow.

Bill Liao


Bill Liao is a Chinese-Australian-Irish entrepreneur, investor, former diplomat, business mentor, author, passionate leader and speaker, with a distinguished record in business development and community activism. He is co-founder of the CoderDojo movement which teaches children worldwide how to code, and of Weforest, which has a stated goal of planting a hundred million trees around the equator. He has been a member of official delegations to the COP climate change summits. His career in tech and business encompasses two unicorn companies and launching the world’s first bio-tech accelerator. He has participated as an investor and volunteer for The Hunger Project in Uganda, New York, and Mexico. He is a general partner of SOSV, a venture capital fund of over $1B, and founder of the SOSV Momentum Pre-accelerator program. Bill’s current focus is Quantum Software.

Barbara Logan

Barbara co-founded the LifeStar Institute to catalyze a global effort to prevent age-related diseases within a radically compressed timeframe. LifeStar organized the collaboration of a number of eminent scientists to author The Demographic and Biomedical Case for Late-Life Interventions in Aging in Science Translational Medicine (July, 2010). Since 2009, she has chosen to focus her efforts in the field as a member of the SRF board. In the mid-1980s, she was President and COO of ComputerLand Corporation, then the world’s largest retailer of personal computers. A life-long entrepreneur, she and her husband have created a variety of successful businesses together. They currently live on Oahu.

Oliver Medvedik, Ph.D.


Oliver Medvedik, Co-founder of Genspace citizen science laboratory in Brooklyn NY, earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. As part of his doctoral work he has used single-celled budding yeast as a model system to map the genetic pathways that underlie the processes of aging in more complex organisms, such as humans. Prior to arriving in Boston for his doctoral studies, he has lived most of his life in New York City. He obtained his bachelor’s degree in biology from Hunter College, City University of New York.

Since graduating from Harvard, he has worked as a biotechnology consultant, taught molecular biology to numerous undergraduates at Harvard University and mentored two of Harvard’s teams for the international genetically engineered machines competition (IGEM) held annually at M.I.T. Oliver is also the Director of The Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, New York City. The Maurice Kanbar Center for Biomedical Engineering is open to all Cooper Union faculty and students working on bioengineering projects requiring equipment and space for tissue culture, genetic engineering, biomechanics, and related research. Faculty that is currently using the facility are pursuing groundbreaking biomedical research in such fields as biomedical devices, tissue engineering, obstructive sleep apnea biomechanics also collaborating with several major New York City-based hospitals. The Kanbar Center continues to provide space for undergraduate teams participating in the international genetically engineered competition (iGEM) during the summer, as well as space for courses that offer a biological laboratory component.

Kevin Perrott


Kevin Perrott obtained a PhD in the Campisi Lab of the Buck Institute studying the effects of natural compounds on senescence.  He became a cofounder of Oisin Biotechnologies, a biotech developing gene therapies for age-related disease.  A cancer survivor with a sense of urgency, Kevin founded OpenCures, a for-benefit company whose Mission is the creation of the OpenCures Database, a valuable open-access resource of human multiomic information obtained from individuals measuring and sharing their health data.

Paul A. Spiegel, J.D.

Paul Spiegel is a thought leader, an international speaker and a longtime activist in the fields of longevity and transhumanism.  He is a board member of the Lifespan Extension Advocacy Foundation, the American Longevity Alliance, Humanity Plus, and SENS Research Foundation, and is a former board member of the International Longevity Alliance.  He is a legal advisor to the U.S. Transhumanist Party the Lifeboat Foundation and the Brain Preservation Foundation, he is a member of Health Extension and and he provides legal counsel for many longevity-related and transhumanist enterprises.

Paul is an attorney specializing in longevity biomedicine and has counseled and consulted for the longevity community since 2006.  His San Francisco firm, Eclectic Law, provides general counsel services to startups and established companies in biotechnology, longevity medicine and other fields.  He is founder of Libertas Biomedical, LLC, which seeks friendly offshore venues for companies to promote longevity research and treatment with greater freedom than is allowed in the United States or the European Union.  As of October, 2019, he will serve the Republic of San Marino as Honorary Consul for California and three other Southwestern states.

Paul graduated from the University of California, Berkeley in 1979, from Berkeley Law School in 1983, attended Harvard Law School, the University of Paris, Sorbonne, International Christian University in Tokyo and speaks 5 languages, including English, French, Spanish and Italian. Trained in international business law, he worked on Wall Street, on Montgomery Street and in Tokyo before entering private practice in San Francisco.  Long an advocate of progressive ideas and legal causes, he has focused on longevity, transhumanism, regenerative medicine and the biology of aging.

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2024 SENS Research Foundation – ALL RIGHTS RESERVED

Thank you for Subscribing to the SENS Research Foundation Newsletter.

You can also


You can